Sanofi-aventis 4Q 4Q Revenues: $10.2 billion (+4%) 4Q Earnings: $674.8 million (+18%)* FY Revenues: $42.0 billion (+6%) FY Earnings: $7.5 billion (+37%)* Comments: Pharmaceutical sales were $9.0 billion (+3%) in 4Q09 and $37.0 billion(+4%) for FY09. Sales of Lantus were $1.1 billion in the quarter (+17%). Sales of Apidra were up 30% in the quarter to $53 million. Lovenox sales were up 8% to $1.1 billion. Taxotere sales were $763.6 million, up 4%. Sales of Eloxatin were d...